Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Acta Pharmaceutica Sinica ; (12): 218-221, 2015.
Article in Chinese | WPRIM | ID: wpr-251791

ABSTRACT

To enhance the quality and efficiency of ozagrel by investigating the differences between the ozagrel polymorphs in bioavailability. Solid ozagrel in different polymorph forms were orally administered to SD rats. An HPLC method was established to determinate plasma level of ozagrel. The bioavailabilities of two polymorph forms were calculated and compared. The pharmacokinetic parameters of ozagrel, were as follows: Cmax was 32.72 ± 17.04 and 34.01 ± 19.13 mg · L(-1), respectively; AUC0-t was 61.14 ± 14.76 and 85.56 ± 18.08 mg · L(-1) · h, respectively; t½ was 1.53 ± 0.51 and 4.73 ± 3.00 h, respectively. There was no significant difference in pharmacokinetic parameters between form I and II polymorphs of ozagrel while the t½ of form II is longer, which indicates that the use of form II polymorph as pharmaceutical product may prolong the effective action time in clinics. This would help the polymorph quality control in drug production.


Subject(s)
Animals , Biological Availability , Chromatography, High Pressure Liquid , Methacrylates , Chemistry , Pharmacokinetics , Rats , Rats, Sprague-Dawley
2.
Acta Pharmaceutica Sinica ; (12): 1268-1272, 2011.
Article in Chinese | WPRIM | ID: wpr-232999

ABSTRACT

Four crystalline forms of clopidogrel bisulfate were characterized by analytical techniques. Aiming to research the absorption characteristics of clopidogrel bisulfate polymorphs after taken orally by rat, and to estimate the influence of crystal form to pharmacodynamic action, four crystalline forms of clopidogrel bisulfate were administered intragastrically to rats, and high performance liquid chromatography (HPLC) was used to measure the contents of clopidogrel bisulfate and its metabolite in rat plasma. The metabolite of clopidogrel bisulfate was detected in rat plasma. There were significant deviations among four crystalline forms in the areas under curve of the metabolite of clopidogrel bisulfate. We concluded that the different crystal forms of clopidogrel bisulfate showed different pharmacokinetic characteristics, which might affect pharmacodynamic action.


Subject(s)
Absorption , Administration, Oral , Animals , Area Under Curve , Calorimetry, Differential Scanning , Chromatography, High Pressure Liquid , Crystallization , Male , Platelet Aggregation Inhibitors , Chemistry , Pharmacokinetics , Random Allocation , Rats , Rats, Wistar , Spectrophotometry, Infrared , Ticlopidine , Blood , Chemistry , Pharmacokinetics , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL